Share price: 160.00p

Block Listing Update and Total Voting Rights

21st July 2020

Cello Health plc

(“Cello” or the “Company”)

Block Listing Update

Total Voting Rights

The Company notifies that, since the date of its most recent block listing update, a total of 170,667 new ordinary shares of 10p each in the share capital of the Company have been issued and allotted (pursuant to the Company’s PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010) and admitted to trading in accordance with the block listing. An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.

 As at today’s date, Cello’s issued share capital comprises 107,143,531 ordinary shares of 10 pence each (“Ordinary Shares”), of which 453,000 Ordinary Shares are held in treasury. The total number of current voting rights in the Company is therefore 106,690,531 Ordinary Shares, which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Enquiries

Cello Health

020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Group Finance Director

Cenkos Securities

  020 7397 8900

Giles Balleny

Harry Hargreaves

Buchanan

  020 7466 5000

Mark Court

Jamie Hooper

Sophie Wills

 

BLOCK LISTING SIX MONTHLY RETURN

Name of applicant:

Cello Health plc

Name of scheme:

PSP Option Scheme 2010, Approved Share Option Plan 2009 and Unapproved Scheme 2010

Period of return:

From:

21 January 2020

To:

21 July 2020

Balance of unallotted securities under scheme(s) from previous return:

1,685,819

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Less: Number of securities issued/allotted under scheme(s) during period:

170,667

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,515,152

Name of contact:

Mark Bentley, Group Finance Director

Telephone number of contact:

020 7812 8460

 

Contact Us

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150